Pharma & Healthcare
Global Immunotherapeutic Drugs Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 779
- Pages: 106
- Figures: 136
- Views: 16
Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.
Market Analysis and Insights: Global Immunotherapeutic Drugs Market
The global Immunotherapeutic Drugs market is projected to grow from US$ 199710 million in 2024 to US$ 379440 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast period.
The US & Canada market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Immunotherapeutic Drugs include Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Immunotherapeutic Drugs is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Immunotherapeutic Drugs industry development. In 2023, global % revenue of Immunotherapeutic Drugs went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Immunotherapeutic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immunotherapeutic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunotherapeutic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunotherapeutic Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immunotherapeutic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunotherapeutic Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Segment by Type
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunotherapeutic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapeutic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunotherapeutic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Immunotherapeutic Drugs Market
The global Immunotherapeutic Drugs market is projected to grow from US$ 199710 million in 2024 to US$ 379440 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast period.
The US & Canada market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Immunotherapeutic Drugs include Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Immunotherapeutic Drugs is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Immunotherapeutic Drugs industry development. In 2023, global % revenue of Immunotherapeutic Drugs went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Immunotherapeutic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immunotherapeutic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunotherapeutic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunotherapeutic Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immunotherapeutic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunotherapeutic Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Segment by Type
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunotherapeutic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapeutic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunotherapeutic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibody
1.2.3 Vaccines
1.2.4 Checkpoint Inhibitor
1.2.5 Interferon
1.3 Market by Application
1.3.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapeutic Drugs Market Perspective (2019-2030)
2.2 Global Immunotherapeutic Drugs Growth Trends by Region
2.2.1 Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunotherapeutic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Immunotherapeutic Drugs Market Dynamics
2.3.1 Immunotherapeutic Drugs Industry Trends
2.3.2 Immunotherapeutic Drugs Market Drivers
2.3.3 Immunotherapeutic Drugs Market Challenges
2.3.4 Immunotherapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immunotherapeutic Drugs by Players
3.1.1 Global Immunotherapeutic Drugs Revenue by Players (2019-2024)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immunotherapeutic Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Immunotherapeutic Drugs Market Concentration Ratio
3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2023
3.5 Global Key Players of Immunotherapeutic Drugs Head office and Area Served
3.6 Global Key Players of Immunotherapeutic Drugs, Product and Application
3.7 Global Key Players of Immunotherapeutic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapeutic Drugs Breakdown Data by Type
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030)
5 Immunotherapeutic Drugs Breakdown Data by Application
5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunotherapeutic Drugs Market Size (2019-2030)
6.2 North America Immunotherapeutic Drugs Market Size by Type
6.2.1 North America Immunotherapeutic Drugs Market Size by Type (2019-2024)
6.2.2 North America Immunotherapeutic Drugs Market Size by Type (2025-2030)
6.2.3 North America Immunotherapeutic Drugs Market Share by Type (2019-2030)
6.3 North America Immunotherapeutic Drugs Market Size by Application
6.3.1 North America Immunotherapeutic Drugs Market Size by Application (2019-2024)
6.3.2 North America Immunotherapeutic Drugs Market Size by Application (2025-2030)
6.3.3 North America Immunotherapeutic Drugs Market Share by Application (2019-2030)
6.4 North America Immunotherapeutic Drugs Market Size by Country
6.4.1 North America Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Immunotherapeutic Drugs Market Size by Country (2019-2024)
6.4.3 North America Immunotherapeutic Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immunotherapeutic Drugs Market Size (2019-2030)
7.2 Europe Immunotherapeutic Drugs Market Size by Type
7.2.1 Europe Immunotherapeutic Drugs Market Size by Type (2019-2024)
7.2.2 Europe Immunotherapeutic Drugs Market Size by Type (2025-2030)
7.2.3 Europe Immunotherapeutic Drugs Market Share by Type (2019-2030)
7.3 Europe Immunotherapeutic Drugs Market Size by Application
7.3.1 Europe Immunotherapeutic Drugs Market Size by Application (2019-2024)
7.3.2 Europe Immunotherapeutic Drugs Market Size by Application (2025-2030)
7.3.3 Europe Immunotherapeutic Drugs Market Share by Application (2019-2030)
7.4 Europe Immunotherapeutic Drugs Market Size by Country
7.4.1 Europe Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Immunotherapeutic Drugs Market Size by Country (2019-2024)
7.4.3 Europe Immunotherapeutic Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immunotherapeutic Drugs Market Size (2019-2030)
8.2 China Immunotherapeutic Drugs Market Size by Type
8.2.1 China Immunotherapeutic Drugs Market Size by Type (2019-2024)
8.2.2 China Immunotherapeutic Drugs Market Size by Type (2025-2030)
8.2.3 China Immunotherapeutic Drugs Market Share by Type (2019-2030)
8.3 China Immunotherapeutic Drugs Market Size by Application
8.3.1 China Immunotherapeutic Drugs Market Size by Application (2019-2024)
8.3.2 China Immunotherapeutic Drugs Market Size by Application (2025-2030)
8.3.3 China Immunotherapeutic Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Immunotherapeutic Drugs Market Size (2019-2030)
9.2 Asia Immunotherapeutic Drugs Market Size by Type
9.2.1 Asia Immunotherapeutic Drugs Market Size by Type (2019-2024)
9.2.2 Asia Immunotherapeutic Drugs Market Size by Type (2025-2030)
9.2.3 Asia Immunotherapeutic Drugs Market Share by Type (2019-2030)
9.3 Asia Immunotherapeutic Drugs Market Size by Application
9.3.1 Asia Immunotherapeutic Drugs Market Size by Application (2019-2024)
9.3.2 Asia Immunotherapeutic Drugs Market Size by Application (2025-2030)
9.3.3 Asia Immunotherapeutic Drugs Market Share by Application (2019-2030)
9.4 Asia Immunotherapeutic Drugs Market Size by Region
9.4.1 Asia Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Immunotherapeutic Drugs Market Size by Region (2019-2024)
9.4.3 Asia Immunotherapeutic Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapeutic Drugs Introduction
11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapeutic Drugs Introduction
11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapeutic Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Immunotherapeutic Drugs Introduction
11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.6.5 AbbVie Recent Developments
11.7 ELI Lilly
11.7.1 ELI Lilly Company Details
11.7.2 ELI Lilly Business Overview
11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.7.5 ELI Lilly Recent Developments
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Immunotherapeutic Drugs Introduction
11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.8.5 Amgen Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.9.5 AstraZeneca Recent Developments
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Details
11.10.2 Bristol-Mysers Squibb Business Overview
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.10.5 Bristol-Mysers Squibb Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibody
1.2.3 Vaccines
1.2.4 Checkpoint Inhibitor
1.2.5 Interferon
1.3 Market by Application
1.3.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapeutic Drugs Market Perspective (2019-2030)
2.2 Global Immunotherapeutic Drugs Growth Trends by Region
2.2.1 Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunotherapeutic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Immunotherapeutic Drugs Market Dynamics
2.3.1 Immunotherapeutic Drugs Industry Trends
2.3.2 Immunotherapeutic Drugs Market Drivers
2.3.3 Immunotherapeutic Drugs Market Challenges
2.3.4 Immunotherapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immunotherapeutic Drugs by Players
3.1.1 Global Immunotherapeutic Drugs Revenue by Players (2019-2024)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immunotherapeutic Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Immunotherapeutic Drugs Market Concentration Ratio
3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2023
3.5 Global Key Players of Immunotherapeutic Drugs Head office and Area Served
3.6 Global Key Players of Immunotherapeutic Drugs, Product and Application
3.7 Global Key Players of Immunotherapeutic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapeutic Drugs Breakdown Data by Type
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030)
5 Immunotherapeutic Drugs Breakdown Data by Application
5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunotherapeutic Drugs Market Size (2019-2030)
6.2 North America Immunotherapeutic Drugs Market Size by Type
6.2.1 North America Immunotherapeutic Drugs Market Size by Type (2019-2024)
6.2.2 North America Immunotherapeutic Drugs Market Size by Type (2025-2030)
6.2.3 North America Immunotherapeutic Drugs Market Share by Type (2019-2030)
6.3 North America Immunotherapeutic Drugs Market Size by Application
6.3.1 North America Immunotherapeutic Drugs Market Size by Application (2019-2024)
6.3.2 North America Immunotherapeutic Drugs Market Size by Application (2025-2030)
6.3.3 North America Immunotherapeutic Drugs Market Share by Application (2019-2030)
6.4 North America Immunotherapeutic Drugs Market Size by Country
6.4.1 North America Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Immunotherapeutic Drugs Market Size by Country (2019-2024)
6.4.3 North America Immunotherapeutic Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immunotherapeutic Drugs Market Size (2019-2030)
7.2 Europe Immunotherapeutic Drugs Market Size by Type
7.2.1 Europe Immunotherapeutic Drugs Market Size by Type (2019-2024)
7.2.2 Europe Immunotherapeutic Drugs Market Size by Type (2025-2030)
7.2.3 Europe Immunotherapeutic Drugs Market Share by Type (2019-2030)
7.3 Europe Immunotherapeutic Drugs Market Size by Application
7.3.1 Europe Immunotherapeutic Drugs Market Size by Application (2019-2024)
7.3.2 Europe Immunotherapeutic Drugs Market Size by Application (2025-2030)
7.3.3 Europe Immunotherapeutic Drugs Market Share by Application (2019-2030)
7.4 Europe Immunotherapeutic Drugs Market Size by Country
7.4.1 Europe Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Immunotherapeutic Drugs Market Size by Country (2019-2024)
7.4.3 Europe Immunotherapeutic Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immunotherapeutic Drugs Market Size (2019-2030)
8.2 China Immunotherapeutic Drugs Market Size by Type
8.2.1 China Immunotherapeutic Drugs Market Size by Type (2019-2024)
8.2.2 China Immunotherapeutic Drugs Market Size by Type (2025-2030)
8.2.3 China Immunotherapeutic Drugs Market Share by Type (2019-2030)
8.3 China Immunotherapeutic Drugs Market Size by Application
8.3.1 China Immunotherapeutic Drugs Market Size by Application (2019-2024)
8.3.2 China Immunotherapeutic Drugs Market Size by Application (2025-2030)
8.3.3 China Immunotherapeutic Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Immunotherapeutic Drugs Market Size (2019-2030)
9.2 Asia Immunotherapeutic Drugs Market Size by Type
9.2.1 Asia Immunotherapeutic Drugs Market Size by Type (2019-2024)
9.2.2 Asia Immunotherapeutic Drugs Market Size by Type (2025-2030)
9.2.3 Asia Immunotherapeutic Drugs Market Share by Type (2019-2030)
9.3 Asia Immunotherapeutic Drugs Market Size by Application
9.3.1 Asia Immunotherapeutic Drugs Market Size by Application (2019-2024)
9.3.2 Asia Immunotherapeutic Drugs Market Size by Application (2025-2030)
9.3.3 Asia Immunotherapeutic Drugs Market Share by Application (2019-2030)
9.4 Asia Immunotherapeutic Drugs Market Size by Region
9.4.1 Asia Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Immunotherapeutic Drugs Market Size by Region (2019-2024)
9.4.3 Asia Immunotherapeutic Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapeutic Drugs Introduction
11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapeutic Drugs Introduction
11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapeutic Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Immunotherapeutic Drugs Introduction
11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.6.5 AbbVie Recent Developments
11.7 ELI Lilly
11.7.1 ELI Lilly Company Details
11.7.2 ELI Lilly Business Overview
11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.7.5 ELI Lilly Recent Developments
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Immunotherapeutic Drugs Introduction
11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.8.5 Amgen Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.9.5 AstraZeneca Recent Developments
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Details
11.10.2 Bristol-Mysers Squibb Business Overview
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.10.5 Bristol-Mysers Squibb Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Vaccines
Table 4. Key Players of Checkpoint Inhibitor
Table 5. Key Players of Interferon
Table 6. Global Immunotherapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Immunotherapeutic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Immunotherapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Immunotherapeutic Drugs Market Share by Region (2019-2024)
Table 10. Global Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Immunotherapeutic Drugs Market Share by Region (2025-2030)
Table 12. Immunotherapeutic Drugs Market Trends
Table 13. Immunotherapeutic Drugs Market Drivers
Table 14. Immunotherapeutic Drugs Market Challenges
Table 15. Immunotherapeutic Drugs Market Restraints
Table 16. Global Immunotherapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Immunotherapeutic Drugs Revenue Share by Players (2019-2024)
Table 18. Global Top Immunotherapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2023)
Table 19. Global Immunotherapeutic Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Immunotherapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Immunotherapeutic Drugs, Headquarters and Area Served
Table 22. Global Key Players of Immunotherapeutic Drugs, Product and Application
Table 23. Global Key Players of Immunotherapeutic Drugs, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Immunotherapeutic Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Immunotherapeutic Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Immunotherapeutic Drugs Revenue Share by Application (2019-2024)
Table 31. Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Immunotherapeutic Drugs Revenue Share by Application (2025-2030)
Table 33. North America Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Immunotherapeutic Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Immunotherapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Immunotherapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Immunotherapeutic Drugs Product
Table 68. Roche Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 69. Roche Recent Developments
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Immunotherapeutic Drugs Product
Table 73. Merck Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 74. Merck Recent Developments
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Immunotherapeutic Drugs Product
Table 78. Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 79. Novartis Recent Developments
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Immunotherapeutic Drugs Product
Table 83. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 84. Johnson & Johnson Recent Developments
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Immunotherapeutic Drugs Product
Table 88. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Developments
Table 90. AbbVie Company Details
Table 91. AbbVie Business Overview
Table 92. AbbVie Immunotherapeutic Drugs Product
Table 93. AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 94. AbbVie Recent Developments
Table 95. ELI Lilly Company Details
Table 96. ELI Lilly Business Overview
Table 97. ELI Lilly Immunotherapeutic Drugs Product
Table 98. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 99. ELI Lilly Recent Developments
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Immunotherapeutic Drugs Product
Table 103. Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 104. Amgen Recent Developments
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Immunotherapeutic Drugs Product
Table 108. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 109. AstraZeneca Recent Developments
Table 110. Bristol-Mysers Squibb Company Details
Table 111. Bristol-Mysers Squibb Business Overview
Table 112. Bristol-Mysers Squibb Immunotherapeutic Drugs Product
Table 113. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 114. Bristol-Mysers Squibb Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Immunotherapeutic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibody Features
Figure 4. Vaccines Features
Figure 5. Checkpoint Inhibitor Features
Figure 6. Interferon Features
Figure 7. Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Immunotherapeutic Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other Case Studies
Figure 12. Immunotherapeutic Drugs Report Years Considered
Figure 13. Global Immunotherapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Immunotherapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Immunotherapeutic Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Immunotherapeutic Drugs Market Share by Players in 2023
Figure 17. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2023
Figure 19. North America Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 21. North America Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 22. North America Immunotherapeutic Drugs Market Share by Country (2019-2030)
Figure 23. United States Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 27. Europe Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 28. Europe Immunotherapeutic Drugs Market Share by Country (2019-2030)
Figure 29. Germany Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 37. China Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 38. Asia Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 40. Asia Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 41. Asia Immunotherapeutic Drugs Market Share by Region (2019-2030)
Figure 42. Japan Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Country (2019-2030)
Figure 52. Brazil Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 59. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 60. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 61. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 63. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 64. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 65. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 67. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Vaccines
Table 4. Key Players of Checkpoint Inhibitor
Table 5. Key Players of Interferon
Table 6. Global Immunotherapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Immunotherapeutic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Immunotherapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Immunotherapeutic Drugs Market Share by Region (2019-2024)
Table 10. Global Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Immunotherapeutic Drugs Market Share by Region (2025-2030)
Table 12. Immunotherapeutic Drugs Market Trends
Table 13. Immunotherapeutic Drugs Market Drivers
Table 14. Immunotherapeutic Drugs Market Challenges
Table 15. Immunotherapeutic Drugs Market Restraints
Table 16. Global Immunotherapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Immunotherapeutic Drugs Revenue Share by Players (2019-2024)
Table 18. Global Top Immunotherapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2023)
Table 19. Global Immunotherapeutic Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Immunotherapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Immunotherapeutic Drugs, Headquarters and Area Served
Table 22. Global Key Players of Immunotherapeutic Drugs, Product and Application
Table 23. Global Key Players of Immunotherapeutic Drugs, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Immunotherapeutic Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Immunotherapeutic Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Immunotherapeutic Drugs Revenue Share by Application (2019-2024)
Table 31. Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Immunotherapeutic Drugs Revenue Share by Application (2025-2030)
Table 33. North America Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Immunotherapeutic Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Immunotherapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Immunotherapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Immunotherapeutic Drugs Product
Table 68. Roche Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 69. Roche Recent Developments
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Immunotherapeutic Drugs Product
Table 73. Merck Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 74. Merck Recent Developments
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Immunotherapeutic Drugs Product
Table 78. Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 79. Novartis Recent Developments
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Immunotherapeutic Drugs Product
Table 83. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 84. Johnson & Johnson Recent Developments
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Immunotherapeutic Drugs Product
Table 88. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Developments
Table 90. AbbVie Company Details
Table 91. AbbVie Business Overview
Table 92. AbbVie Immunotherapeutic Drugs Product
Table 93. AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 94. AbbVie Recent Developments
Table 95. ELI Lilly Company Details
Table 96. ELI Lilly Business Overview
Table 97. ELI Lilly Immunotherapeutic Drugs Product
Table 98. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 99. ELI Lilly Recent Developments
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Immunotherapeutic Drugs Product
Table 103. Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 104. Amgen Recent Developments
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Immunotherapeutic Drugs Product
Table 108. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 109. AstraZeneca Recent Developments
Table 110. Bristol-Mysers Squibb Company Details
Table 111. Bristol-Mysers Squibb Business Overview
Table 112. Bristol-Mysers Squibb Immunotherapeutic Drugs Product
Table 113. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)
Table 114. Bristol-Mysers Squibb Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Immunotherapeutic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibody Features
Figure 4. Vaccines Features
Figure 5. Checkpoint Inhibitor Features
Figure 6. Interferon Features
Figure 7. Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Immunotherapeutic Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other Case Studies
Figure 12. Immunotherapeutic Drugs Report Years Considered
Figure 13. Global Immunotherapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Immunotherapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Immunotherapeutic Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Immunotherapeutic Drugs Market Share by Players in 2023
Figure 17. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2023
Figure 19. North America Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 21. North America Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 22. North America Immunotherapeutic Drugs Market Share by Country (2019-2030)
Figure 23. United States Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 27. Europe Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 28. Europe Immunotherapeutic Drugs Market Share by Country (2019-2030)
Figure 29. Germany Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 37. China Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 38. Asia Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 40. Asia Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 41. Asia Immunotherapeutic Drugs Market Share by Region (2019-2030)
Figure 42. Japan Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Country (2019-2030)
Figure 52. Brazil Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 59. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 60. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 61. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 63. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 64. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 65. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 67. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Gadolinium DOTA Meglumine Market Research Report 2025
Apr 23, 25
Global Crisaborole API Market Research Report 2025
Apr 23, 25
Global Glyceryl Monooleate Market Research Report 2025
Apr 23, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232